MNL-00008 [5]
Proprietary and Confidential Page
43
of
55
UVA, Skin Type VI, 11011
TREATMENT #
1
2
3
4
5
6
7
8
9
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
PRIMARY DOSE
(JOULES)
5.5
5.5
7.0
7.0
8.5
8.5 10.0 10.0 11.5 11.5 13.0 13.0 14.5 14.5 16.0 16.0 17.5 17.5 19.0 19.0 20.0 20.0 20.0 20.0 20.0
SECONDARY
DOSE (JOULES)
4.0
5.0
6.0
7.0
8.0
9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0 19.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0
UVA, Skin Type VI, 3/week
TREATMENT #
1
2
3
4
5
6
7
8
9
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
PRIMARY DOSE
(JOULES)
6.5
7.5
8.5
9.5 10.5 11.5 12.5 13.5 14.5 15.5 16.5 17.5 18.5 19.5 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0
SECONDARY
DOSE (JOULES)
4.0
5.0
6.0
7.0
8.0
9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0 19.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0
UVA, Skin Type VI, 2/week
TREATMENT #
1
2
3
4
5
6
7
8
9
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
PRIMARY DOSE
(JOULES)
6.5
8.0
9.5 11.0 12.5 14.0 15.5 17.0 18.5 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0
SECONDARY
DOSE (JOULES)
4.0
5.0
6.0
7.0
8.0
9.0 10.0 11.0 12.0 13.0 14.0 15.0 16.0 17.0 18.0 19.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0 20.0
23.3
UVA Maintenance Phase Protocols:
1/week, 3/month, 2/month, 1/month
Maximum Number of Treatments = 4
ALL SKIN TYPES
: Dose should be held steady at last clearance phase dose.